Showing results (621-630 of 1,088) with videos related to

Sort By:
Pageof 109
Open Heart|October 22, 2014
Percutaneous coronary intervention causes a rapid but transient mobilisation of CD34(+)CD45(-) cellsGareth J Padfield, Olga Tura-Ceide, Elizabeth Freyer, et al.
International Journal of Environmental Research and Public Health|May 28, 2022
The Role of Tobacco Smoking in the Efficacy of Brief Alcohol Intervention: Results from a Randomized Controlled TrialFilipa Krolo, Sophie Baumann, Anika Tiede, et al.
Cancer Treatment Reviews|September 26, 2021
The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomasBenoit You, Gilles Freyer, Antonio Gonzalez-Martin, et al.
Cell Proliferation|May 10, 2019
Effect of inoculum density on human-induced pluripotent stem cell expansion in 3D bioreactorsSelina Greuel, Güngör Hanci, Mike Böhme, et al.
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|February 9, 2012
Sirolimus-eluting stents for the treatment of infrapopliteal arteries in chronic limb ischemia: long-term clinical and angiographic follow-upMartin Werner, Andrej Schmidt, Michael Freyer, et al.
Nano Letters|June 15, 2019
Explaining the Unusual Photoluminescence of Semiconductor Nanocrystals Doped via Cation ExchangeAbigail R Freyer, Peter C Sercel, Zhentao Hou, et al.
Journal of Cancer Survivorship : Research and Practice|December 19, 2022
The integration of primary care and childhood cancer survivorship care: a scoping reviewJulia Stal, Sarah E Piombo, Lynn Kysh, et al.
Glia|March 3, 1998
Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytesR R Schumann, D Pfeil, D Freyer, et al.
Physics in Medicine and Biology|February 18, 2003
Methods for measuring the infrared spectra of biological cellsJudith R Mourant, Rowena R Gibson, Tamara M Johnson, et al.
JNCI Cancer Spectrum|June 30, 2020
Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7)Olivier Colomban, Michel Tod, Julien Peron, et al.
Pageof 109